Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Significant Blood Sugar Improvement With Xultophy(R) Compared to Insulin Glargine U-100 When Used as Add-On to Oral Diabetes Medications
2018-06-25 20:05
Top 50 In Global Pharma By 2025 -- Luye Pharma Group Announces "Whole Value Chain" Global Collaboration Strategy
2018-06-25 13:35
WuXi Biologics and Harbour BioMed Announce Strategic Development and Manufacturing Partnership
2018-06-25 07:55
Tresiba® Demonstrated Significantly Improved Blood Sugar Control and Lower Rates of Hypoglycaemia Versus Insulin Glargine U300 in Real-World Evidence Study
2018-06-23 22:12
Ozempic® Provided Greater Weight Reductions for Adults With a Baseline BMI ≥25kg/m2 Than Those With Lower Baseline BMI <25kg/m2, in a SUSTAIN 7 Post-hoc Analysis
2018-06-23 22:09
Oral Semaglutide Demonstrated Significant Reduction in Blood Sugar vs Placebo in PIONEER 1 Trial
2018-06-23 22:06
PharmaEngine Announces Positive Topline Results from Global Pivotal Trial of PEP503 (NBTXR3) in Soft Tissue Sarcoma
2018-06-22 08:07
Oracle Health Sciences Earns Frost & Sullivan's Enabling Technology Leadership Award for its eClinical Platform, Clinical One
2018-06-21 21:00
Prosten Health Holdings Limited officially renamed as "China Brilliant Global Limited"
2018-06-21 13:27
TOT BIOPHARM's 16,000L-capacity monoclonal antibodies production base put into operation
2018-06-21 10:40
Frost & Sullivan 2018 Award for Innovation in Artificial Intelligence for Aging Research and Drug Development
2018-06-20 22:41
CStone enrolls first patient in Phase I study for MEK inhibitor CS3006 in Australia
2018-06-20 19:07
Merck and Alibaba Health Announce Collaboration to Develop Patient-Centric Digital Services in China
2018-06-20 15:15
TUV Rheinland launches first Radiological Health and Safety Convention
2018-06-20 08:00
Luye Pharma Bolsters Its Global Analgesics Portfolio with China Class 1.1 New Compound LY03012 to Start Phase I Clinical Trials
2018-06-19 21:52
China Biologic Announces Receipt of Non-Binding Acquisition Proposal
2018-06-19 20:00
Kazia Releases Preliminary Cantrixil Phase I Data
2018-06-19 18:00
Alpha Biopharma Announces Series A Financing
2018-06-19 17:36
NeuroVive Out-licenses Targeted LHON Therapy to BridgeBio Pharma's New Subsidiary Fortify Therapeutics
2018-06-19 04:39
SOPHiA GENETICS Acquires Interactive Biosoftware to Drive Growth and Accelerate Data-Driven Medicine Adoption Around the World
2018-06-16 14:00
1
355
356
357
358
359
412